Failure of fluconazole in treating cutaneous leishmaniasis caused by Leishmania guyanensis in the Brazilian Amazon: An open, nonrandomized phase 2 trial.

• Hauptverfasser: Valeska Albuquerque Francesconi (Verfasst von), Fabio Francesconi (Verfasst von), Rajendranath Ramasawmy (Verfasst von), Gustavo Adolfo Sierra Romero (Verfasst von), Maria das Graças Costa Alecrim (Verfasst von)
• Format: Buch
• Veröffentlicht: Public Library of Science (PLoS), 2018-02-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

The treatment of Leishmaniasis caused by Leishmania (Viannia) guyanensis is based on a weak strength of evidence from very few clinical trials and some case series reports. Current treatment guidelines recommend pentamidine isethionate or meglumine antimoniate (Glucantime) as the first-line choices....